Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Schedule of Revenue Recognition (Details)

v3.20.2
Revenue Recognition - Schedule of Revenue Recognition (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Total revenues $ 3,519,187 $ 2,927,466 $ 9,112,563 $ 8,006,382
Functional Neurosurgery Navigation - Disposable Products        
Total revenues 1,840,060 1,854,251 4,573,484 5,212,460
Therapy - Disposable Products        
Total revenues 64,095 78,800 81,925
Therapy - Services        
Total revenues 50,000 25,000 200,000
Therapy Revenue Subtotal        
Total revenues 114,095 103,800 281,925
Biologics and Drug Delivery - Disposable Products        
Total revenues 419,946 491,257 1,000,276 957,673
Biologics and Drug Delivery - Services        
Total revenues 1,054,622 72,500 2,646,050 338,112
Biologics and Drug Delivery Revenue Subtotal        
Total revenues 1,474,568 563,757 3,646,326 1,295,785
Capital Equipment and Software - Systems and Software Products        
Total revenues 73,544 184,825 377,445 700,517
Capital Equipment and Software - Services        
Total revenues 131,015 210,538 411,508 515,695
Capital Equipment and Software Revenue Subtotal        
Total revenues $ 204,559 $ 395,363 $ 788,953 $ 1,216,212